The Acute Effect of Vaping on Food Intake
3 other identifiers
interventional
40
1 country
1
Brief Summary
This study assesses the acute effects of a standardized 20-minute vaping episode compared to a non-vaping control condition on ad libitum food intake during a 30-minute buffet meal, occurring approximately 45 minutes after the vaping episode
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2020
CompletedFirst Posted
Study publicly available on registry
January 6, 2020
CompletedStudy Start
First participant enrolled
September 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2022
CompletedResults Posted
Study results publicly available
November 13, 2023
CompletedDecember 5, 2023
November 1, 2023
12 months
January 3, 2020
September 18, 2023
November 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Energy Intake
Energy intake in kilocalories (kcal) during the ad libitum buffet meal will be measured via directly weighed food provision and waste (food/energy intake is calculated by difference).
intake was assessed over a 30 minute meal
Secondary Outcomes (14)
Dietary Added Sugar Intake
intake was assessed over a 30 minute meal
Dietary Sugar Intake
intake was assessed over a 30 minute meal
Dietary Fat Intake
intake was assessed over a 30 minute meal
Dietary Carbohydrate Intake
intake was assessed over a 30 minute meal
Dietary Protein Intake
intake was assessed over a 30 minute meal
- +9 more secondary outcomes
Study Arms (2)
Vaping to Control Group
EXPERIMENTALParticipants in this arm will undergo the vaping condition during the first visit and the control condition during the second visit.
Control to Vaping Group
EXPERIMENTALParticipants in this arm will undergo the control condition during the first visit and the vaping condition during the second visit.
Interventions
Participants will be asked to use a JUUL device to vape 20 puffs over 20 minutes. Participants will use JUUL pods with \~5% nicotine by weight. The anticipated amount of nicotine that will be absorbed with 20 puffs is approximately 1.6 mg, which is equal to approximately 1.5 cigarettes.
Participants will have access to an uncharged JUUL device with an empty pod for 20 minutes.
Eligibility Criteria
You may qualify if:
- years of age (ID card verified)
- Reports either everyday e-cigarette use with liquid containing at least 0.3% (\~3 mg/ml) nicotine or some day e-cigarette use ( at least 3 days a week) with liquid containing at least 3% (\~30 mg/ml) nicotine for the past 30 days.
You may not qualify if:
- being unwilling to consume the foods provided due to: a) dietary limitations or preferences or b) allergies to the foods provided.
- being unwilling to take 20 puffs from a JUUL device containing a 5% nicotine pod
- self-reported current, diagnosed medical condition(s) will be excluded automatically: heart-related conditions (e.g., recent heart attack/stroke, coronary heart disease), severe immune system disorders (e.g., HIV/AIDS, multiple sclerosis), respiratory disorders (e.g., COPD, asthma), kidney diseases, liver diseases (e.g., cirrhosis), or seizures
- observed high blood pressure at screening (systolic \>140; diastolic \>90)
- self-reported current, diagnosed psychiatric conditions or who report current psychiatric treatment or psychotropic medication use
- past month use of cocaine, opioids, benzodiazepines, methamphetamine, or other (non-cannabis) illicit drugs
- self-report of \>25 days out of the past 30 for alcohol use or \>20 days out of the past 30 for cannabis use.
- women who are breast-feeding or test positive for pregnancy (by urinalysis at screening)
- women using progestin-IUDS for birth control
- women using birth control injections (e.g., Depo-Provera)
- women who received a hysterectomy and still have ovaries present
- self-report intending to quit tobacco/nicotine products in the next 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- Pennington Biomedical Research Centercollaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Center for the Study of Tobacco Products
Richmond, Virginia, 23220, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Caroline Cobb
- Organization
- Virginia Commonwealth University
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline Cobb (Amey), PhD
Virginia Commonwealth University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2020
First Posted
January 6, 2020
Study Start
September 22, 2021
Primary Completion
September 21, 2022
Study Completion
September 21, 2022
Last Updated
December 5, 2023
Results First Posted
November 13, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share